Inozyme Pharma News

Inozyme Pharma | 8-K: Inozyme Pharma Reports First Quarter 2024 Financial Results and Provides Business Highlights

May 7 08:34 ET

Inozyme Pharma | DEFA14A: Others

Apr 26 16:45 ET

Inozyme Pharma | DEF 14A: Definitive information statements

Apr 26 16:42 ET

Inozyme Pharma | 8-K: Current report

Apr 8 06:47 ET

Inozyme Pharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 12 08:42 ET

Inozyme Pharma | 8-K: Current report

Mar 12 08:37 ET

Inozyme Pharma | S-3: Registration statement for specified transactions by certain issuers

Nov 7, 2023 16:07 ET

Inozyme Pharma | 8-K: Inozyme Pharma Reports Third Quarter 2023 Financial Results and Provides Business Highlights

Nov 7, 2023 08:31 ET

Inozyme Pharma | 8-K: Current report

Sep 26, 2023 16:12 ET

Inozyme Pharma | 8-K: Inozyme Pharma Reports Second Quarter 2023 Financial Results and Provides Business Highlights

Aug 8, 2023 08:37 ET

Inozyme Pharma | 8-K: Current report

Jul 28, 2023 17:19 ET

Inozyme Pharma | 8-K: Current report

Jul 26, 2023 07:42 ET

Inozyme Pharma | 8-K: Current report

Jun 27, 2023 16:05 ET

Inozyme Pharma | 8-K: Current report

Jun 14, 2023 16:36 ET

Inozyme Pharma | 8-K: Inozyme Pharma Reports First Quarter 2023 Financial Results and Provides Business Highlights

May 9, 2023 08:35 ET

Inozyme Pharma | DEFA14A: Others

Apr 27, 2023 08:36 ET

Inozyme Pharma | DEF 14A: Definitive proxy statements

Apr 27, 2023 08:31 ET

Inozyme Pharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 22, 2023 08:49 ET

Inozyme Pharma | 8-K: Current report

Mar 22, 2023 08:35 ET

Inozyme Pharma | 8-K: Current report

Mar 10, 2023 17:25 ET